SBIR Phase I: A Novel Photobiological Water Treatment Process for More Efficient Water Recovery in Advanced Water Reclamation and Brackish Groundwater Desalination Facilities
SBIR 第一阶段:一种新型光生物水处理工艺,可在高级水回收和微咸水淡化设施中更有效地回收水
基本信息
- 批准号:1648495
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-15 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research Phase I project is the potential to impact water scarcity in arid and semi-arid geographies within the US and beyond. The proposed photobiological water treatment process utilizes the natural power of photosynthetic microorganisms (diatoms) and sunlight without the use of hazardous chemicals or non-renewable energy to remove contaminants such as silica, calcium, iron, manganese, phosphorus and nitrogen from the concentrated waste streams (brines) from advanced water reclamation and brackish groundwater desalination facilities. Additional clean, (re)usable water can be obtained from the treated brine quite cost-effectively, while reducing the volume of brine by 50% and producing algal biomass as a marketable by-product. This technology will reduce the environmental impact and also potentially improve the efficiency of water treatment. This Phase I project will have broader impacts on the advancement of science and technology related to environmental microbiology, water reuse and water resource management. The experimental data to be generated in this project could reveal many characteristics and fundamental chemistry and biology of brackish water diatoms that have not been studied in detail, as compared with those found in the freshwater and marine environment. The technical objectives in this Phase I research project are to investigate the feasibility of a diatom-based photobiological process for scalant and nutrient removal to recover more fresh water from reverse osmosis concentrate; to characterize the byproducts of this process including organic matter and algal biomass; and to investigate the scale-up challenges. The challenges and opportunities include: (1) the optimization of the biomass growth and constituent removal, including diatom strain screening, (2) impacts of toxic elements, chlorine residuals, salinity, pH, temperature, light sources, intensity, and duration, (3) formation and characterization of byproducts, (4) removal of synthetic organic compounds, such as pharmaceuticals and personal care products, (5) photobiological reactor configuration and hydraulics, and (6) possible uses and economic values of algal biomass. Among them, the major challenges are the possible soluble organic byproduct formation and the relatively modest silica uptake rate. Bench- and pilot-scale experiments will be conducted to optimize the photobiological process to enable a full-scale application with a reasonable footprint. Careful diatom strain/species selection and more detailed chemical and biochemical analyses will also facilitate further process optimization and understanding of the fate of byproducts, their impacts on subsequent desalination, and possible control strategies.
这个小企业创新研究第一阶段项目的更广泛的影响/商业潜力是影响美国及其他地区干旱和半干旱地区水资源短缺的潜力。 所提出的光生物水处理工艺利用光合微生物(硅藻)和阳光的自然力量,而不使用危险化学品或不可再生能源,以从来自先进的水回收和微咸水地下水淡化设施的浓缩废水流(盐水)中去除污染物,如二氧化硅、钙、铁、锰、磷和氮。 额外的清洁,(可再)使用的水可以从处理过的盐水中获得,非常具有成本效益,同时减少50%的盐水体积,并产生藻类生物质作为可销售的副产品。 这项技术将减少对环境的影响,并有可能提高水处理的效率。 这一第一阶段项目将对环境微生物学、水再利用和水资源管理方面的科学和技术进步产生更广泛的影响。 与淡水和海洋环境中发现的硅藻相比,本项目产生的实验数据可以揭示尚未详细研究的微咸水硅藻的许多特征和基本化学和生物学。 第一阶段研究项目的技术目标是研究基于生物降解的光生物工艺去除结垢和营养物的可行性,以从反渗透浓缩液中回收更多的淡水;表征该工艺的副产品,包括有机物和藻类生物量;并研究规模扩大的挑战。 挑战和机遇包括:(1)生物质生长和成分去除的优化,包括硅藻菌株筛选,(2)有毒元素、氯残留物、盐度、pH、温度、光源、强度和持续时间的影响,(3)副产物的形成和表征,(4)合成有机化合物如药物和个人护理产品的去除,(5)光生物反应器配置和水力学;(6)藻类生物质的可能用途和经济价值。 其中,主要的挑战是可能的可溶性有机副产物的形成和相对适度的二氧化硅吸收率。 将进行实验室和中试规模的实验,以优化光生物学过程,从而实现具有合理足迹的全面应用。 仔细的硅藻菌株/物种选择和更详细的化学和生物化学分析也将有助于进一步优化工艺,了解副产品的命运,它们对后续脱盐的影响以及可能的控制策略。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A novel photobiological process for reverse osmosis concentrate treatment using brackish water diatoms
利用苦咸水硅藻进行反渗透浓缩处理的新型光生物工艺
- DOI:10.2166/ws.2017.142
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Ikehata, Keisuke;Zhao, Yuanyuan;Ma, Jingshu;Komor, Andrew T.;Maleky, Nima;Anderson, Michael A.
- 通讯作者:Anderson, Michael A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keisuke Ikehata其他文献
Degradation of <em>N</em>-nitrosamines and 1,4-dioxane using vacuum ultraviolet irradiation (UV<sub>254+185 nm</sub> or UV<sub>172 nm</sub>)
- DOI:
10.1016/j.chemosphere.2021.130326 - 发表时间:
2021-09-01 - 期刊:
- 影响因子:
- 作者:
Takahiro Fujioka;Hitoshi Kodamatani;Hai Duc Minh Tran;Atsushi Fujioka;Koki Hino;Takumi Yoshikawa;Daisuke Inoue;Keisuke Ikehata - 通讯作者:
Keisuke Ikehata
Keisuke Ikehata的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Novel Self-Closing, Transcatheter, Edge-to-Edge Repair Device to Percutaneously Treat Tricuspid Valve Regurgitation Using Jugular or Femoral Vein Access
SBIR 第一阶段:新型自闭合、经导管、边对边修复装置,利用颈静脉或股静脉通路经皮治疗三尖瓣反流
- 批准号:
2322197 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase I: Novel Camera-Projector Device Leveraging Markerless Skin Registration and Projected Augmented Reality Software to Enable Navigation for Minimally Invasive Procedures
SBIR 第一阶段:新型相机投影仪设备利用无标记皮肤配准和投影增强现实软件实现微创手术导航
- 批准号:
2321906 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase I: Universal Crystal Growth Capsule and Novel Wafer Dicing Tool for In-Space Manufacturing
SBIR 第一阶段:用于太空制造的通用晶体生长舱和新型晶圆切割工具
- 批准号:
2419346 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase I: Optimizing Composition of Novel Molten Alkali Metal Borates for Carbon Dioxide Capture
SBIR 第一阶段:优化用于二氧化碳捕获的新型熔融碱金属硼酸盐的成分
- 批准号:
2332658 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase II: Novel progesterone biosensor for monitoring fertility health
SBIR II 期:用于监测生育健康的新型黄体酮生物传感器
- 批准号:
2341568 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Novel size-changing, gadolinium-free contrast agent for magnetic resonance angiography
SBIR II 期:用于磁共振血管造影的新型尺寸变化、无钆造影剂
- 批准号:
2322379 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Development of novel artificial intelligence (AI)-enabled, non-invasive, heart attack diagnostics
SBIR 第一阶段:开发新型人工智能 (AI) 支持的非侵入性心脏病诊断
- 批准号:
2208248 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase I: Consolidated platform to engineer and produce novel biopolymers for improved biologics
SBIR 第一阶段:设计和生产新型生物聚合物以改进生物制剂的综合平台
- 批准号:
2233560 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
SBIR Phase I: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
SBIR 第一期:用于新型 T 细胞免疫疗法的工程诱导胸腺上皮细胞
- 批准号:
2234041 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant














{{item.name}}会员




